211 related articles for article (PubMed ID: 15770212)
1. Impact of combined (18)F-FDG PET/CT in head and neck tumours.
Syed R; Bomanji JB; Nagabhushan N; Hughes S; Kayani I; Groves A; Gacinovic S; Hydes N; Visvikis D; Copland C; Ell PJ
Br J Cancer; 2005 Mar; 92(6):1046-50. PubMed ID: 15770212
[TBL] [Abstract][Full Text] [Related]
2. FDG PET/CT interobserver agreement in head and neck cancer: FDG and CT measurements of the primary tumor site.
Jackson T; Chung MK; Mercier G; Ozonoff A; Subramaniam RM
Nucl Med Commun; 2012 Mar; 33(3):305-12. PubMed ID: 22227560
[TBL] [Abstract][Full Text] [Related]
3. Impact of FDG-PET/CT fused imaging on tumor volume assessment of head-and-neck squamous cell carcinoma: intermethod and interobserver variations.
Murakami R; Uozumi H; Hirai T; Nishimura R; Katsuragawa S; Shiraishi S; Toya R; Tashiro K; Kawanaka K; Oya N; Tomiguchi S; Yamashita Y
Acta Radiol; 2008 Jul; 49(6):693-9. PubMed ID: 18568563
[TBL] [Abstract][Full Text] [Related]
4. FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma.
Schwartz DL; Ford E; Rajendran J; Yueh B; Coltrera MD; Virgin J; Anzai Y; Haynor D; Lewellyn B; Mattes D; Meyer J; Phillips M; Leblanc M; Kinahan P; Krohn K; Eary J; Laramore GE
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):129-36. PubMed ID: 15629603
[TBL] [Abstract][Full Text] [Related]
5. Clinical values for abnormal ¹⁸F-FDG uptake in the head and neck region of patients with head and neck squamous cell carcinoma.
Lee HS; Kim JS; Roh JL; Choi SH; Nam SY; Kim SY
Eur J Radiol; 2014 Aug; 83(8):1455-60. PubMed ID: 24929443
[TBL] [Abstract][Full Text] [Related]
6. Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma.
Murakami R; Uozumi H; Hirai T; Nishimura R; Shiraishi S; Ota K; Murakami D; Tomiguchi S; Oya N; Katsuragawa S; Yamashita Y
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):377-82. PubMed ID: 17321066
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous positron emission tomography (PET) assessment of metabolism with ¹⁸F-fluoro-2-deoxy-d-glucose (FDG), proliferation with ¹⁸F-fluoro-thymidine (FLT), and hypoxia with ¹⁸fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot study.
Vera P; Bohn P; Edet-Sanson A; Salles A; Hapdey S; Gardin I; Ménard JF; Modzelewski R; Thiberville L; Dubray B
Radiother Oncol; 2011 Jan; 98(1):109-16. PubMed ID: 21056487
[TBL] [Abstract][Full Text] [Related]
8. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.
Kitagawa Y; Nishizawa S; Sano K; Ogasawara T; Nakamura M; Sadato N; Yoshida M; Yonekura Y
J Nucl Med; 2003 Feb; 44(2):198-206. PubMed ID: 12571209
[TBL] [Abstract][Full Text] [Related]
9. FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer.
Kitagawa Y; Sano K; Nishizawa S; Nakamura M; Ogasawara T; Sadato N; Yonekura Y
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):63-71. PubMed ID: 12483411
[TBL] [Abstract][Full Text] [Related]
10. 18F-FET PET compared with 18F-FDG PET and CT in patients with head and neck cancer.
Pauleit D; Zimmermann A; Stoffels G; Bauer D; Risse J; Flüss MO; Hamacher K; Coenen HH; Langen KJ
J Nucl Med; 2006 Feb; 47(2):256-61. PubMed ID: 16455631
[TBL] [Abstract][Full Text] [Related]
11. Post-treatment surveillance of head and neck cancer: pitfalls in the interpretation of FDG PET-CT/MRI.
Meerwein CM; Queiroz M; Kollias S; Hüllner M; Veit-Haibach P; Huber GF
Swiss Med Wkly; 2015; 145():w14116. PubMed ID: 25701645
[TBL] [Abstract][Full Text] [Related]
12. Detection and quantification of focal uptake in head and neck tumours: (18)F-FDG PET/MR versus PET/CT.
Varoquaux A; Rager O; Poncet A; Delattre BM; Ratib O; Becker CD; Dulguerov P; Dulguerov N; Zaidi H; Becker M
Eur J Nucl Med Mol Imaging; 2014 Mar; 41(3):462-75. PubMed ID: 24108458
[TBL] [Abstract][Full Text] [Related]
13. Dual modality of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical carcinoma of unknown primary.
Freudenberg LS; Fischer M; Antoch G; Jentzen W; Gutzeit A; Rosenbaum SJ; Bockisch A; Egelhof T
Med Princ Pract; 2005; 14(3):155-60. PubMed ID: 15863988
[TBL] [Abstract][Full Text] [Related]
14. Combined PET-CT in the head and neck: part 1. Physiologic, altered physiologic, and artifactual FDG uptake.
Blodgett TM; Fukui MB; Snyderman CH; Branstetter BF; McCook BM; Townsend DW; Meltzer CC
Radiographics; 2005; 25(4):897-912. PubMed ID: 16009814
[TBL] [Abstract][Full Text] [Related]
15. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Schaefferkoetter JD; Carlson ER; Heidel RE
J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
[TBL] [Abstract][Full Text] [Related]
16. Interobserver variability among measurements of the maximum and mean standardized uptake values on (18)F-FDG PET/CT and measurements of tumor size on diagnostic CT in patients with pulmonary tumors.
Huang YE; Chen CF; Huang YJ; Konda SD; Appelbaum DE; Pu Y
Acta Radiol; 2010 Sep; 51(7):782-8. PubMed ID: 20707663
[TBL] [Abstract][Full Text] [Related]
17. FDG-PET/CT-guided intensity modulated head and neck radiotherapy: a pilot investigation.
Schwartz DL; Ford EC; Rajendran J; Yueh B; Coltrera MD; Virgin J; Anzai Y; Haynor D; Lewellen B; Mattes D; Kinahan P; Meyer J; Phillips M; Leblanc M; Krohn K; Eary J; Laramore GE
Head Neck; 2005 Jun; 27(6):478-87. PubMed ID: 15772953
[TBL] [Abstract][Full Text] [Related]
18. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791
[TBL] [Abstract][Full Text] [Related]
19. 1-[11C]-acetate PET imaging in head and neck cancer--a comparison with 18F-FDG-PET: implications for staging and radiotherapy planning.
Sun A; Sörensen J; Karlsson M; Turesson I; Langström B; Nilsson P; Cederblad L; Bertling J; Riklund K; Johansson S
Eur J Nucl Med Mol Imaging; 2007 May; 34(5):651-657. PubMed ID: 17146654
[TBL] [Abstract][Full Text] [Related]
20. Intraobserver and interobserver variability in GTV delineation on FDG-PET-CT images of head and neck cancers.
Breen SL; Publicover J; De Silva S; Pond G; Brock K; O'Sullivan B; Cummings B; Dawson L; Keller A; Kim J; Ringash J; Yu E; Hendler A; Waldron J
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):763-70. PubMed ID: 17379435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
